Pillar Pacific Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
$1.59M Sell
10,405
-589
-5% -$90.1K 0.12% 117
2020
Q4
$1.72M Sell
10,994
-4,546
-29% -$710K 0.14% 112
2020
Q3
$1.78M Buy
15,540
+110
+0.7% +$12.6K 0.17% 107
2020
Q2
$1.73M Buy
15,430
+195
+1% +$21.9K 0.18% 107
2020
Q1
$1.37M Buy
15,235
+1,275
+9% +$114K 0.18% 110
2019
Q4
$1.51M Sell
13,960
-2,770
-17% -$299K 0.15% 126
2019
Q3
$1.64M Sell
16,730
-520
-3% -$50.9K 0.18% 119
2019
Q2
$2.26M Sell
17,250
-110
-0.6% -$14.4K 0.25% 107
2019
Q1
$2.35M Sell
17,360
-690
-4% -$93.2K 0.27% 107
2018
Q4
$1.76M Sell
18,050
-1,445
-7% -$141K 0.23% 112
2018
Q3
$2.71M Sell
19,495
-395
-2% -$54.9K 0.29% 109
2018
Q2
$2.47M Buy
19,890
+285
+1% +$35.4K 0.29% 109
2018
Q1
$2.19M Buy
19,605
+885
+5% +$98.7K 0.26% 113
2017
Q4
$2.24M Sell
18,720
-4,065
-18% -$486K 0.27% 112
2017
Q3
$3.2M Buy
22,785
+1,565
+7% +$220K 0.41% 98
2017
Q2
$2.58M Buy
21,220
+15
+0.1% +$1.83K 0.35% 108
2017
Q1
$2.57M Buy
21,205
+1,242
+6% +$151K 0.36% 106
2016
Q4
$2.44M Sell
19,963
-8,055
-29% -$986K 0.38% 101
2016
Q3
$3.43M Buy
28,018
+1,558
+6% +$191K 0.54% 84
2016
Q2
$3.09M Buy
26,460
+1,198
+5% +$140K 0.52% 83
2016
Q1
$3.52M Buy
25,262
+1,625
+7% +$226K 0.61% 74
2015
Q4
$4.51M Buy
23,637
+220
+0.9% +$42K 0.81% 49
2015
Q3
$3.66M Buy
23,417
+795
+4% +$124K 0.69% 62
2015
Q2
$4.09M Buy
22,622
+16,410
+264% +$2.97M 0.71% 65
2015
Q1
$1.08M Buy
6,212
+375
+6% +$65K 0.19% 117
2014
Q4
$1.08M Sell
5,837
-13
-0.2% -$2.41K 0.19% 117
2014
Q3
$971K Sell
5,850
-295
-5% -$49K 0.18% 117
2014
Q2
$960K Buy
6,145
+795
+15% +$124K 0.18% 123
2014
Q1
$814K Buy
5,350
+360
+7% +$54.8K 0.17% 124
2013
Q4
$663K Sell
4,990
-110
-2% -$14.6K 0.13% 136
2013
Q3
$593K Buy
5,100
+600
+13% +$69.8K 0.13% 139
2013
Q2
$415K Buy
+4,500
New +$415K 0.1% 157